Literature DB >> 6968322

Conversion of plasma progesterone to deoxycorticosterone in men, nonpregnant and pregnant women, and adrenalectomized subjects.

C A Winkel, L Milewich, C R Parker, N F Gant, E R Simpson, P C MacDonald.   

Abstract

During the third trimester of human pregnancy the concentrations of deoxycorticosterone (DOC) in maternal plasma are 4-50 times those in nonpregnant women and men. It has been suggested that the increased amount of DOC in maternal plasma originates in the fetal compartment. We considered an alternate explanation for the high levels of DOC in plasma or near-term pregnant women, viz., that DOC may be derived in part from 21-hydroxylation of maternal plama progesterone. To test this hyposthesis we measured the fractional conversion of plasma progesterone to DOC from the relationship between the 3H:14C ratio of the infused tracers, [3H]progesterone and [14C]-DOC, and the 3H:14C ratio or urinary 3 alpha,21-dihydroxy-5 beta-pregnan-20-one (tetrahydro-DOC). The fractional conversion of plasma progesterone to DOC ([rho](BU)P-DOC), measured in this manner, was 0.007 +/- 0.001 (mean +/- SEM, n = 26) in the subjects of this study. The values for [rho](BU)P-DOC varied widely among subjects (0.002-0.022) but the range of values for [rho](BU)P-DOC was similar among women pregnant with an anencephalic or dead fetus, nonpregnant and adrenalectomized women, and men. The transfer constant of conversion of progesterone to DOC in plasma, [rho](BB)P-DOC, remained constant in a nonpregnant woman during the infusion of nonradiolabeled progesterone at rates of 0-14 mg/h. Based on the results of these studied, we conclude that DOC is formed by extra-adrenal 21-hydroxylation of plasma progesterone and that the rate of formation of DOC by this pathway is proportional to the concentration of progesterone in plasma.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6968322      PMCID: PMC371655          DOI: 10.1172/JCI109918

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  24 in total

1.  Plasma deoxycorticosterone in man.

Authors:  R D Brown; C A Strott
Journal:  J Clin Endocrinol Metab       Date:  1971-06       Impact factor: 5.958

2.  Placental estrogen biosynthesis during human pregnancy.

Authors:  P K Siiteri; P C MacDonald
Journal:  J Clin Endocrinol Metab       Date:  1966-07       Impact factor: 5.958

Review 3.  Steroid dynamics under steady-state conditions.

Authors:  D T Baird; R Horton; C Longcope; J F Tait
Journal:  Recent Prog Horm Res       Date:  1969

4.  Maternal and umbilical cord plasma concentrations of steroids of the pregn-4-ene C-21-yl sulfate series at term.

Authors:  M Schweitzer; C Branchaud; C J Giroud
Journal:  Steroids       Date:  1969-11       Impact factor: 2.668

5.  [Studies on the secretion and metabolism of desoxycorticosterone in health subjects and in patients].

Authors:  W Nolten; P Vecsei; M Köhler; I Purjesz; H P Wolff
Journal:  Verh Dtsch Ges Inn Med       Date:  1968

6.  Characterization of the 21-yl sulfates of 11-beta, 17-alpha,21-trihydroxypregn-4-ene-3,20-dione; 17-alpha,21-dihydroxypregn-4-ene-3, 11,20-trione; 11-beta,21-dihydroxyregn-4-ene-3,20-dione; 21-hydroxypregn-4-ene-3, 11,20-trione and 21-hydroxypregn-4-ene,3,20-dione in human cord plasma.

Authors:  C Branchaud; M Schweitzer; C J Giroud
Journal:  Steroids       Date:  1969-08       Impact factor: 2.668

7.  Formation of C-21 steroid sulphates and glucosiduronates by previable human foetuses perfused with [4-14C]progesterone.

Authors:  C E Bird; S Solomon; N Wiqvist; E Diczfalusy
Journal:  Biochim Biophys Acta       Date:  1965-07-08

8.  Androstenedione production and interconversion rates measured in peripheral blood and studies on the possible site of its conversion to testosterone.

Authors:  R Horton; J F Tait
Journal:  J Clin Invest       Date:  1966-03       Impact factor: 14.808

9.  Plasma precursors of estrogen. I. Extent of conversion of plasma delta-4-androstenedione to estrone in normal males and nonpregnant normal, castrate and adrenalectomized females.

Authors:  P C MacDonald; R P Rombaut; P K Siiteri
Journal:  J Clin Endocrinol Metab       Date:  1967-08       Impact factor: 5.958

10.  Desoxycorticosterone secretion rates in hyperadrenocorticism.

Authors:  M G Crane; J J Harris
Journal:  J Clin Endocrinol Metab       Date:  1966-10       Impact factor: 5.958

View more
  6 in total

Review 1.  The enigma of continual plasma volume expansion in pregnancy: critical role of the renin-angiotensin-aldosterone system.

Authors:  Crystal A West; Jennifer M Sasser; Chris Baylis
Journal:  Am J Physiol Renal Physiol       Date:  2016-10-05

2.  Regulation of extraadrenal steroid 21-hydroxylase activity. Increased conversion of plasma progesterone to deoxycorticosterone during estrogen treatment of women pregnant with a dead fetus.

Authors:  P C MacDonald; S Cutrer; S C MacDonald; M L Casey; C R Parker
Journal:  J Clin Invest       Date:  1982-02       Impact factor: 14.808

3.  Deoxycorticosterone biosynthesis in human kidney: potential for formation of a potent mineralocorticosteroid in its site of action.

Authors:  C A Winkel; E R Simpson; L Milewich; P C MacDonald
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

4.  Metabolism of deoxycorticosterone and deoxycorticosterone sulfate in men and women.

Authors:  M L Casey; P C MacDonald
Journal:  J Clin Invest       Date:  1982-08       Impact factor: 14.808

5.  Origin of urinary nonconjugated 19-nor-deoxycorticosterone and metabolism of infused radiolabeled 19-nor-deoxycorticosterone in men and women.

Authors:  M L Casey; A Guerami; L Milewich; C E Gomez-Sanchez; P C MacDonald
Journal:  J Clin Invest       Date:  1985-04       Impact factor: 14.808

Review 6.  Physiologic and pharmacokinetic changes in pregnancy.

Authors:  Maged M Costantine
Journal:  Front Pharmacol       Date:  2014-04-03       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.